Yousif Capital Management, LLC Nektar Therapeutics Transaction History

Yousif Capital Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 02, 2023	SELL	$0.64 - $3.15 $6,713 - $33,043	-10,490 Reduced 8.82%	108,435 $75,000
Q4 2022 Jan 09, 2023	SELL	$2.03 - $4.28 $64,361 - $135,697	-31,705 Reduced 21.05%	118,925 $0
Q3 2022 Nov 04, 2022	SELL	$3.04 - $5.14 $9,582 - $16,201	-3,152 Reduced 2.05%	150,630 $482,000
Q2 2022 Aug 01, 2022	SELL	$3.17 - $6.17 $35,583 - $69,258	-11,225 Reduced 6.8%	153,782 $584,000
Q1 2022 May 12, 2022	SELL	$4.16 - $13.72 $436 - $1,440	-105 Reduced 0.06%	165,007 $889,000

Q4 2021 Jan 31, 2022	BUY	$10.83 - $18.41 $1.79 Million - $3.04 Million	165,112 New	165,112 $2.23 Million

128

111M

150K

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $219M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

Get notified when there are updates to the investment portfolio of Yousif Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Yousif Capital Management, LLC with notifications on news.